Success Stories: Our Team Obtained NIW Approval for a Scientist from Sri Lanka in Just 3 Days, with No RFE Issued

Client’s Testimonial:

“This is really awesome news and thank you very much for everything to make this happen!”

On February 8^th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Scientist

Country of Origin: Sri Lanka

State of Residence at the Time of Filing: Ohio

Approval Notice Date: February 8^th, 2024

Processing Time: 3 days (Premium Processing Requested)

Case Summary:

One of our most valued clients envisaged himself achieving his professional goals in the United States without having to deal with any extra Requests for Evidence (RFE). His wish came true when the North America Immigration Law Group agreed to assist him in getting his NIW petition granted without any complications. Our careful team examined his extensive study experience and strong qualifications in the biochemistry field that he chose. As a result, we highlighted our client’s extraordinary success story, assisting him in securing a National Interest Waiver in just 3 days without incurring an RFE.

We added the following information to his NIW petition packet:

The Client’s Proposed Endeavor- As an expert in the field of biochemistry, our client proposed to continue his research on developing new methodologies for engineering and characterizing novel proteins and antibodies in order to further biomedical studies, the biotechnology industry, and healthcare.
The Great Substantial Merit and National importance of his research- We deduced that his research advancing his proposed endeavor is of great importance because it provides the foundation for innovations in biotechnology, biomedicine, and healthcare that add significant value to the global economy.
Funding Support- It is worth noting that his study has received funding from a reputable organization, such as the National Institutes of Health (NIH). This funding support therefore serves as evidence that he has delivered key insights into the medicinal properties of natural products to advance the development of novel therapeutic treatments for a range of human ailments.
Publishing, Citation, and Peer-Reviews Experience- In addition, we underlined that he has published 3 peer-reviewed journal articles (1 of them first-authored) 1 first-authored conference abstract, and 1 preprint in authoritative peer-reviewed journals. His peers have cited his work 17 times, indicating both the originality and effectiveness of his methods and results.
Accomplished Victory- The innovative protein and antibody engineering developments by our client are paving the way for health-enhancing technologies, ultimately allowing the healthcare and pharmaceutical sectors to thrive and provide populations with better health services. His advances are also crucial for driving U.S. leadership in protein engineering technology and applications, enhancing health outcomes across the nation. Therefore, the adjudication officers have acknowledged the significance of our client’s proposed endeavor, which has bolstered public health and the U.S. economy.

We are pleased that USCIS granted him NIW approval. Thanks to the USCIS premium processing upgrade, our client’s petition adjudication was expedited, allowing for approval in just three days. We thank our client for his assistance during the NIW petition preparation process, and we wish him the best of luck in his future undertakings.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.